Pasar al contenido principal

Avanzando en el manejo de la Enfermedad de Parkinson: abordando la disfunción autofágica-lisosomal para el desarrollo de herramientas innovadoras de diagnósticos y terapéuticas

PI24/00062

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Salud
Año convocatoria 2024
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Systematic Assessment of Matrix Effect, Recovery, and Process Efficiency Using Three Complementary Approaches, Implications for LC-MS/MS Bioanalysis Applied to Glucosylceramides in Human Cerebrospinal Fluid

  • Castillo-Ribelles, Laura|||0000-0001-9380-7839
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Martinez-Vicente, Marta|||0000-0001-7053-2625
  • Carnicer-Cáceres, Clara
  • Arranz-Amo, Jose Antonio|||0000-0002-2236-4185
The evaluation of matrix effect, recovery, and process efficiency is essential in the validation of LC-MS/MS bioanalytical methods, as they impact assay accuracy, precision, and sensitivity. However, guidelines on bioanalytical method evaluation are not harmonized and can occasionally be ambiguous. To address this need, the study presents an integration of three different approaches to assess these parameters within a single experiment. The first approach examined the variability of peak areas and standard-to-internal standard (IS) ratios between different matrix lots to assess the influence of the analytical system, relative matrix effects, and recovery on method precision. The second strategy evaluates the influence of the overall process on analyte quantification. The third approach calculates both the absolute and relative values of matrix effect, recovery, and process efficiency, as well as their respective IS-normalized factors, to determine the extent to which the IS compensates for the variability introduced by the matrix and recovery fraction. Applying these strategies to an LC-MS/MS method for quantifying glucosylceramides in cerebrospinal fluid addresses the challenges posed by limited sample volume and endogenous analytes, while providing a comprehensive understanding of the factors that influence method performance and promoting adherence to different guideline recommendations. This study supports the importance of a systematic evaluation of matrix effect, recovery, and process efficiency during method validation. Standardized evaluation methodologies would improve data interpretation, enhance method reliability, and contribute to harmonization in in-house bioanalysis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Systematic Assessment of Matrix Effect, Recovery, and Process Efficiency Using Three Complementary Approaches: Implications for LC-MS/MS Bioanalysis Applied to Glucosylceramides in Human Cerebrospinal Fluid

  • Arranz-Amo, Jose Antonio
  • Carnicer, Clara
  • Castillo-Ribelles, Laura
  • Ferrer Costa, Roser
  • Martinez-Vicente, Marta
  • HERNANDEZ-VARA, JORGE
Efecto matriz; Glucosilceramidas; Líquido cefalorraquídeo humano, Matrix Effect; Glucosylceramides; Human cerebrospinal fluid, Efecte matriu; Glucosilceramides; Líquid cefalorraquidi humà, The evaluation of matrix effect, recovery, and process efficiency is essential in the validation of LC-MS/MS bioanalytical methods, as they impact assay accuracy, precision, and sensitivity. However, guidelines on bioanalytical method evaluation are not harmonized and can occasionally be ambiguous. To address this need, the study presents an integration of three different approaches to assess these parameters within a single experiment. The first approach examined the variability of peak areas and standard-to-internal standard (IS) ratios between different matrix lots to assess the influence of the analytical system, relative matrix effects, and recovery on method precision. The second strategy evaluates the influence of the overall process on analyte quantification. The third approach calculates both the absolute and relative values of matrix effect, recovery, and process efficiency, as well as their respective IS-normalized factors, to determine the extent to which the IS compensates for the variability introduced by the matrix and recovery fraction. Applying these strategies to an LC-MS/MS method for quantifying glucosylceramides in cerebrospinal fluid addresses the challenges posed by limited sample volume and endogenous analytes, while providing a comprehensive understanding of the factors that influence method performance and promoting adherence to different guideline recommendations. This study supports the importance of a systematic evaluation of matrix effect, recovery, and process efficiency during method validation. Standardized evaluation methodologies would improve data interpretation, enhance method reliability, and contribute to harmonization in in-house bioanalysis., This work was supported by Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (Spain)-FEDER (PI20/00728 and PI24/00062), Fundación BBVA (NanoERT), and Fundació La Caixa (HR22-00602).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Systematic Assessment of Matrix Effect, Recovery, and Process Efficiency Using Three Complementary Approaches: Implications for LC-MS/MS Bioanalysis Applied to Glucosylceramides in Human Cerebrospinal Fluid

  • Arranz-Amo, Jose Antonio
  • Carnicer, Clara
  • Castillo-Ribelles, Laura
  • Ferrer Costa, Roser
  • Martinez-Vicente, Marta
  • HERNANDEZ-VARA, JORGE
Efecto matriz; Glucosilceramidas; Líquido cefalorraquídeo humano, Matrix Effect; Glucosylceramides; Human cerebrospinal fluid, Efecte matriu; Glucosilceramides; Líquid cefalorraquidi humà, The evaluation of matrix effect, recovery, and process efficiency is essential in the validation of LC-MS/MS bioanalytical methods, as they impact assay accuracy, precision, and sensitivity. However, guidelines on bioanalytical method evaluation are not harmonized and can occasionally be ambiguous. To address this need, the study presents an integration of three different approaches to assess these parameters within a single experiment. The first approach examined the variability of peak areas and standard-to-internal standard (IS) ratios between different matrix lots to assess the influence of the analytical system, relative matrix effects, and recovery on method precision. The second strategy evaluates the influence of the overall process on analyte quantification. The third approach calculates both the absolute and relative values of matrix effect, recovery, and process efficiency, as well as their respective IS-normalized factors, to determine the extent to which the IS compensates for the variability introduced by the matrix and recovery fraction. Applying these strategies to an LC-MS/MS method for quantifying glucosylceramides in cerebrospinal fluid addresses the challenges posed by limited sample volume and endogenous analytes, while providing a comprehensive understanding of the factors that influence method performance and promoting adherence to different guideline recommendations. This study supports the importance of a systematic evaluation of matrix effect, recovery, and process efficiency during method validation. Standardized evaluation methodologies would improve data interpretation, enhance method reliability, and contribute to harmonization in in-house bioanalysis., This work was supported by Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (Spain)-FEDER (PI20/00728 and PI24/00062), Fundación BBVA (NanoERT), and Fundació La Caixa (HR22-00602).